Neoantigen Discovery Capitalize on NeoSight, an end-to-end neoantigen discovery platform that combines Whole Exome Sequencing and advanced bioinformatics to support personalized cancer immunotherapy. Target oncology researchers, clinics, and pharma collaborators in India and globally, and unlock cross-sell opportunities with existing PreciONC and oligo synthesis customers to offer a full discovery to treatment workflow.

Precision Diagnostics Position PreciONC as a ready-made precision oncology panel for Indian hospitals and diagnostic labs. Its coverage of BRCA1/2, colorectal and lung RNA fusions, hereditary cancers, MSI, and comprehensive cancer profiling, complemented by DSIR ISO accreditation, can fast-track contract wins with clinicians seeking validated molecular testing services and ongoing test programs.

Custom Oligos Promote high-purity custom DNA and RNA oligos at scales up to 10,000 nanomoles with options for modified and long-mer oligos and NGS-grade purification. Target universities, CROs, biotech startups, and gene editing labs that need reliable synthesis for CRISPR guides, probes, and library prep, with a path to recurring orders.

GMP Stem Cells GMP Master Cell Bank manufacturing and iPSC/MSC research tools enable translational programs in biotech and pharma. Focus on Indian biotech firms and CROs pursuing cell therapy, drug discovery and regenerative medicine, and leverage REPROCELL backing to support collaborations with overseas partners on compliant cell product development.

Integrity and Authentication STR profiling across 16 loci aligned with ANSI ATCC ASN-0002 standards provides robust cell line authentication to prevent misidentification and cross contamination. Market to CROs and academic labs as a risk-management and data integrity service, and offer bundled workflows with bioserve services to build end-to-end research pipelines.